Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?

Date publication

août 2022

Journal

Cancers

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BORG Christophe , Dr VERNEREY Dewi , Pr BOULAHDOUR Hatem , Mme HENRIQUES Julie , Mr FALCOZ Antoine

Tous les auteurs :
De Bari B, Lefevre L, Henriques J, Gatta R, Falcoz A, Mathieu P, Borg C, Dinapoli N, Boulahdour H, Boldrini L, Valentini V, Vernerey D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36011035

Résumé

We evaluated the value of pre-treatment positron-emission tomography-computed tomography (PET-CT)-based radiomic features in predicting the locoregional progression-free survival (LR-PFS) of patients with inoperable or unresectable oesophageal cancer.

Mots clés

18-FDG PET-CT, chemoradiotherapy, neoadjuvant treatment, oesophageal cancer, predictive factors, radiomics

Référence

Cancers (Basel). 2022 08 22;14(16):